[Fumao Oil] (Supplemental Notice on Major Information, June 30, 115) Notification from Our Contract Manufacturing Plant Regarding a Specific Batch of Salad Oil Supplied to Us Failing to Meet Regulatory Standards in Testing Results.

1. Date of Incident: 115/07/03

2. Company Name: Fumao Oils Co., Ltd.

3. Relationship with Company (Please enter 'Our Company' or 'Subsidiary'): Our Company

4. Mutual Shareholding Ratio: Not applicable

5. Reason for Occurrence:

On 115/6/30, our contract manufacturing facility, 'Zhonglian Oils Co., Ltd.', notified us of a recall. It was discovered that benzo(a)pyrene (BaP) levels in a portion of salad oil (Batch No.: 0409315) supplied to us did not meet regulatory standards.

6. Response Measures:

1. Upon receiving the notification from the contract manufacturer, all finished products from this batch were immediately halted from shipment. We promptly initiated an investigation into the product distribution channels and commenced product removal and recall operations. On June 30, 115, we completed the reporting process to the relevant regulatory authorities.

2. This is an isolated incident involving an upstream supplier. To strictly adhere to high food safety standards, we have immediately implemented rigorous self-imposed enhanced management protocols. Products will only be released after thorough quality verification confirms compliance with all regulatory standards, ensuring consumer rights are protected with the utmost rigor.

3. Following a comprehensive internal review, the company preliminarily estimates product losses and related follow-up costs at approximately NT$90 million. Going forward, we will uphold our corporate rights in accordance with the law, based on the investigation findings and determination of liability.

7. Other Matters to be Disclosed (If the entity involved in the incident or decision is a publicly listed company or above, this major information simultaneously qualifies as a matter under Article 7, Paragraph 9 of the Enforcement Rules of the Securities Trading Act that significantly impacts shareholder rights or securities prices):

The financial amount related to this non-conforming batch does not have a significant impact on the company's financial condition.